0001161697-22-000469.txt : 20220916
0001161697-22-000469.hdr.sgml : 20220916
20220916170104
ACCESSION NUMBER: 0001161697-22-000469
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220915
FILED AS OF DATE: 20220916
DATE AS OF CHANGE: 20220916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sundaram Preethi
CENTRAL INDEX KEY: 0001872422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 221248664
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form_4.xml
FORM 4 FOR 09-15-2022
X0306
4
2022-09-15
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001872422
Sundaram Preethi
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
Chief Strategy Officer
Common stock, par value $0.001 per share
2022-09-15
4
M
0
18214
5.49
A
18214
D
Common stock, par value $0.001 per share
2022-09-15
4
S
0
18214
14.49
D
0
D
Options to purchase common stock
5.49
2022-09-15
4
M
0
18214
0
A
2022-07-06
2028-07-06
Common Stock
18214
399286
D
Shares were sold for personal reasons and not as a result of any disagreement with the Registrant. Dr. Sundaram remains an officer of the Company.
/s/ Preethi Sundaram
2022-09-16